Detroit, Michigan
Phase 1 cancer trials in Detroit, MI
55 Phase 1 cancer studies are recruiting participants at sites in Detroit as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Detroit at a glance
- 55 studies are recruiting at a site in Detroit.
- By phase: Phase 1 (19), Phase 1/2 (36).
- By sponsor: industry (52), university, hospital or other (3).
- By research area: Lung Cancer (21), Breast Cancer (18), Lymphoma (5), Prostate Cancer (5), Pancreatic Cancer (4), Melanoma (2).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in Detroit
Basic details from each study's public record (the 30 most recently updated of 55). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Phase 1/2 Study of IAM1363 in HER2 Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Study site
- Henry Ford Cancer Institute
- Registry record
- NCT06253871 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- Barbara Ann Karmanos Cancer Center
- Registry record
- NCT07488676 · updated
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BioNTech SE
- Study sites
- Brigitte Harris Cancer Pavilion BHCP · Karmanos Cancer Institute
- Registry record
- NCT06827236 · updated
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- Karmanos Cancer Institute
- Registry record
- NCT07503808 · updated
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genmab
- Study site
- Karmanos Cancer Institute
- Registry record
- NCT05579366 · updated
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Barbara Ann Karmanos Cancer Institute
- Registry record
- NCT07114601 · updated
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Barbara Ann Karmanos Cancer Institute
- Registry record
- NCT07213791 · updated
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Aminex Therapeutics, Inc.
- Study site
- Wayne State University - Barbara Ann Karmanos Cancer Institute
- Registry record
- NCT07287917 · updated
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SystImmune Inc.
- Study site
- Karmanos Cancer Institiute
- Registry record
- NCT06293898 · updated
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Accent Therapeutics
- Study site
- Karmanos Cancer Institute
- Registry record
- NCT06799065 · updated
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Stemline Therapeutics, Inc.
- Study site
- Henry Ford Hospital
- Registry record
- NCT05386108 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Detroit, MI on ClinicalTrials.gov.
Lung cancer studies recruiting in Detroit
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BioNTech SE
- Study site
- Henry Ford Health System
- Registry record
- NCT07111520 · updated
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Inhibrx Biosciences, Inc
- Study site
- Henry Ford Cancer Institute
- Registry record
- NCT04198766 · updated
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BlossomHill Therapeutics
- Study site
- Henry Ford Health
- Registry record
- NCT06706076 · updated
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Sairopa B.V.
- Study site
- Henry Ford Cancer Institute
- Registry record
- NCT05856981 · updated
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kumquat Biosciences Inc.
- Study site
- Karmanos Cancer Institute
- Registry record
- NCT07542704 · updated
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- Henry Ford Hospital - Detroit /ID# 271642
- Registry record
- NCT06772623 · updated
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- DualityBio Inc.
- Registry record
- NCT05914116 · updated
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Frontier Medicines Corporation
- Study site
- Karmanos Cancer Institute
- Registry record
- NCT06244771 · updated
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Study site
- Barbara Ann Karmanos Cancer Institute
- Registry record
- NCT06179069 · updated
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kura Oncology, Inc.
- Study site
- Henry Ford Health System
- Registry record
- NCT06026410 · updated
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BioNTech SE
- Study site
- Brigitte Harris Cancer Pavilion BHCP
- Registry record
- NCT07070232 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Detroit, MI on ClinicalTrials.gov.
Prostate cancer studies recruiting in Detroit
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Regeneron Pharmaceuticals
- Study site
- Henry Ford Health
- Registry record
- NCT03972657 · updated
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Phase 1/2
- Ages 18 to 130
- Male participants
- Sponsor
- AstraZeneca
- Registry record
- NCT07181161 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Detroit, MI on ClinicalTrials.gov.
Melanoma studies recruiting in Detroit
A Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.
- Phase 1
- Ages 18 and older
- Female participants
- Sponsor
- Outpace Bio, Inc.
- Study site
- Karmanos Cancer Institute
- Registry record
- NCT07664735 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Detroit, MI on ClinicalTrials.gov.
Lymphoma studies recruiting in Detroit
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study site
- Children's Hospital of Michigan
- Registry record
- NCT04726241 · updated
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- Nuvalent Inc.
- Study site
- Henry Ford Cancer Institute
- Registry record
- NCT05384626 · updated
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SciTech Development, Inc.
- Study site
- Barbara Ann Karmanos Cancer Institute Wayne State University
- Registry record
- NCT04234048 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Detroit, MI on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Detroit
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BioNTech SE
- Study site
- Karmanos Cancer Institute
- Registry record
- NCT07186842 · updated
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- PanTher Therapeutics
- Study sites
- Henry Ford Health System · Karmanos Cancer Institute
- Registry record
- NCT06673017 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Detroit, MI on ClinicalTrials.gov.
Ask about studies near Detroit
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Michigan
All Michigan locations
145 studies recruiting across 8 cities.
Grand Rapids
72 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections